Ventricular Arrhythmias in Patients With Implanted Cardioverter Defibrillators

Trends in Cardiovascular Medicine

Volumn 22, Issue 7, 2012, Pages 169-173

  John, Roy M ^a   Stevenson, William G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEART FAILURE; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PRIORITY JOURNAL; REVIEW; SHOCK;

DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; HUMANS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 84869075975     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.07.015     Document Type: Review

References (42)

1. Aliot E.M., Stevenson W.G., Almendral-Garrote J.M., et al. EHRA/HRS expert consensus on catheter ablation of ventricular arrhythmias. Heart Rhythm 2009, 6:886-933.
2. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997, 337:1576-1584. Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators.
3. Antzelevitch C., Yan G.X. J-wave syndromes. From cell to bedside. J Electrocardiol 2011, 44:656-661.
4. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone of an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 325:225-237.
5. Bohnen M., Stevenson W.G., Tedrow U.B., et al. Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm 2011, 8:1661-1666.
6. Bourke T., Vaseghi M., Michowitz Y., et al. Neuraxial modulation for refractory ventricular arrhythmias: Value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation 2010, 121:2255-2262.
7. Braunschweig F., Boriani G., Bauer A., et al. Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management. Europace 2010, 12:1673-1690.
8. Burjorjee J.E., Milne B. Propofol for electrical storm: A case report of cardioversion and suppression of ventricular tachycardia by propofol. Can J Anaesth 2002, 49:973-977.
9. Carbucicchio C., Santamaria M., Trevisi N., et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: Short- and long-term outcomes in a prospective single center study. Circulation 2008, 117:462-469.
10. Connolly S.J., Dorian P., Roberts R.S., et al. Comparison of beta-blockers, amiodarone plus beta-blockers or sotalol for prevention of shocks from implantable cardioverter defibrillators: The OPTIC study: A randomized trial. JAMA 2006, 295:165-171.
11. Daubert J.P., Zareba W., Cannom D.S., et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT-II: Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008, 51:1357-1365.
12. Drew B.J., Ackerman M.J., Funk M., et al. Prevention of torsade de pointes in hospital settings: A scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2010, 55:934-947.
13. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) trial. JAMA 2002, 288:3115-3123. Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial Investigators.
14. Exner D.V., Pinski S.L., Wyse D.G., et al. Electrical storm presages non-sudden death: The Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Circulation 2001, 103:2066-2071.
15. Friedman P.A., McClelland R.L., Bamlet W.R., et al. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: The Detect Supraventricular Tachycardia (DETECT SVT) study. Circulation 2006, 113:2871-2879.
16. Healey J.S., Connolly S.J., Gold M.R., et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012, 366:120-129.
17. Hohnloser S.H., Al-Khalidi H.R., Pratt C.M., et al. Electrical storm in patients with an implantable defibrillator-Incidence, features, and preventive therapy: Insights from a randomized trial. Eur Heart J 2006, 27:3027-3032.
18. John R.M., Stevenson W.G. Catheter-based ablation for ventricular arrhythmias. Curr Cardiol Rep 2011, 13:399-406.
19. Jongman J.K., Jepkes-Bruin N., Ramdat Misier A.R., et al. Electrical storms in Brugada syndrome successfully treated with isoproterenol infusion and quinidine orally. Neth Heart J 2007, 15:151-155.
20. Kaufman E.S. Mechanisms and clinical management of inherited channelopathies: Long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome. Heart Rhythm 2009, 6:S51-S55.
21. Knecht S., Sacher F., Wright M., et al. Long-term follow-up of idiopathic ventricular fibrillation ablation: A multicenter study. J Am Coll Cardiol 2009, 54:522-528.
22. Koller M.T., Schaer B., Wolbers M., et al. Death without prior appropriate implantable cardioverter-defibrillator therapy: A competing risk study. Circulation 2008, 117:1918-1926.
23. Kuck K.H., Schaumann A., Eckardt L., et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): A multicentre randomised controlled trial. Lancet 2010, 375:31-40.
24. Levy W.C., Lee K.L., Hellkamp A.S., et al. Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation 2009, 120:835-842.
25. MacFadden D.R., Crystal E., Krahn A.D., et al. Sex differences in implantable cardioverter-defibrillator outcomes: Findings from a prospective defibrillator database. Ann Intern Med 2012, 156:195-203.
26. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias: Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996, 335:1933-1940.
27. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877-883.
28. Packer D.L., Prutkin J.M., Hellkamp A.S., et al. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: Analysis from the Sudden Cardiac Death in Heart Failure Trial. Circulation 2009, 120:2170-2176.
29. Poole J.E., Johnson G.W., Hellkamp A.S., et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008, 359:1009-1017.
30. Reddy V.Y., Reynolds M.R., Neuzil P., et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007, 357:2657-2665.
31. Sacher F., Roberts-Thomson K., Maury P., et al. Epicardial ventricular tachycardia ablation: A multicenter safety study. J Am Coll Cardiol 2010, 55:2366-2372.
32. Saxon L.A., Hayes D.L., Gilliam R., et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: The ALTITUDE Survival Study. Circulation 2010, 122:2359-2367.
33. Sesselberg H.W., Moss A.J., McNitt S., et al. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: A MADIT II substudy. Heart Rhythm 2007, 4:1395-1402.
34. Sinha A.M., Stellbrink C., Schuchert A., et al. Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator. J Cardiovasc Electrophysiol 2004, 15:646-652.
35. Stevenson W.G., John R.M. Ventricular arrhythmias in patients with implanted defibrillators. Circulation 2011, 124:e411-e414.
36. Stevenson W.G., Wilber D.J., Natale A., et al. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: The multicenter thermacool ventricular tachycardia ablation trial. Circulation 2008, 118:2773-2782.
37. Sweeney M.O. Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2004, 27:1292-1305.
38. Sweeney M.O. The contradiction of appropriate shocks in primary prevention ICDs: Increasing and decreasing the risk of death. Circulation 2010, 122:2638-2641.
39. Wathen M.S., DeGroot P.J., Sweeney M.O., et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004, 110:2591-2596. PainFREE Rx II Investigators.
40. Wathen M.S., Sweeney M.O., DeGroot P.J., et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001, 104:796-801.
41. Wilkoff B.L., Williamson B.D., Stern R.S., et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: Results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008, 52:541-550. PREPARE Study Investigators.
42. Yoshida K., Liu T.Y., Scott C., et al. The value of defibrillator electrograms for recognition of clinical ventricular tachycardias and for pace mapping of post-infarction ventricular tachycardia. J Am Coll Cardiol 2010, 56:969-979.